Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EmeisORPEF 53 EV-to-EBIT is 128.71 as of Jul. 20, 2026, which is 321% above its 10-year median of 30.56. GuruFocus rates ORPEF with a GF Score™ of 53/100 and a GF Value™ of $9.39. The stock has 8 warning signs investors should review. Among 468 Healthcare Providers & Services companies, Emeis ranks worse than 94.44% on this metric.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Emeis's Enterprise Value is $11,994 Mil.
Emeis's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $93 Mil. Therefore, Emeis's EV-to-EBIT for today is 128.71.
The historical rank and industry rank for Emeis's EV-to-EBIT or its related term are showing as below:
ORPEF'
s EV-to-EBIT Range Over the Past 10 Years
Min: -3.06 Med: 30.56 Max: 278
Current: 131.42
During the past 13 years, the highest EV-to-EBIT of Emeis was 278.00. The lowest was -3.06. And the median was 30.56.
ORPEF's EV-to-EBIT is ranked worse than 94.44% of 468
companies
in the Healthcare Providers & Services industry
Industry Median: 15.86
vs ORPEF: 131.42
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Emeis's Enterprise Value for the quarter that ended in Dec. 2025 was $11,976 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Emeis's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $93 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Emeis EV-to-EBIT Related Terms
Emeis EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Emeis's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Emeis's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Emeis EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Emeis's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Emeis's EV-to-EBIT falls into.
Emeis's current Enterprise Value is $11,994 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Emeis's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $93 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Emeis (ORPEF) has a EV-to-EBIT of 128.71 as of Jul. 20, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Emeis and its competitors. This is 321% above median its historical median of 30.56. According to the industry distribution chart, Emeis ranks #442 out of 468 companies in the Healthcare Providers & Services industry, placing it in the top 94.4%.
Is Emeis' EV-to-EBIT too high?
Emeis' current EV-to-EBIT of 128.71 is 321% above median its 10-year median of 30.56. The Healthcare Providers & Services industry median EV-to-EBIT is 15.86. Emeis' value of 128.71 is 711.5% above this industry median. Based on the distribution chart, Emeis ranks #442 out of 468 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Emeis has a GF Score™ of 53/100, reflecting its overall financial health beyond just this single metric.
How does Emeis' EV-to-EBIT compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Emeis ranks #442 out of 468 companies for EV-to-EBIT. This places Emeis in the lower half of its industry. The industry median EV-to-EBIT is 15.86. Emeis' value of 128.71 is 711.5% above this benchmark. While the company's 10-year median is 30.56 vs. the industry median of 15.86, Emeis has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.86, based on 468 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Emeis's current EV-to-EBIT of 128.71 is 711.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Emeis and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Emeis's current EV-to-EBIT is 128.71, which is 321% above median its own 10-year median of 30.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Emeis stock overvalued right now?
Emeis (ORPEF) has a current EV-to-EBIT of 128.71. The stock's GF Value™ is $9.39, compared to a current price of $14.22 — trading 51.4% above its estimated fair value. The current EV-to-EBIT is 128.71, which is 321% above median its 10-year median of 30.56 and 711.5% above the Healthcare Providers & Services industry median of 15.86. Emeis' overall GF Score™ is 53/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Emeis (ORPEF), the current EV-to-EBIT is 128.71 as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Emeis (ORPEF) Overvalued in 2026?
Based on GuruFocus' analysis, Emeis stock appears to be overvalued.
The current stock price of $14.22 is trading 51.4% above its estimated GF Value™ of $9.39.
Key valuation signals for ORPEF:
EV-to-EBIT: 128.71 (321% above median its 10-year median of 30.56)
GF Value™: $9.39 vs. price of $14.22 (51.4% above fair value)
Industry Position: 711.5% above the Healthcare Providers & Services median (#442 of 468)
No single metric tells the full story. See the ORPEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Emeis operates a comprehensive care offering of mental health clinics and medical and rehabilitation care, retirement homes, assisted living and home care.
53GF Score
Get the complete analysis for ORPEF
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ORPEF has been successfully added to your 
